Ameriprise Financial Inc Teva Pharmaceutical Industries LTD Transaction History

Ameriprise Financial Inc

  • $364 Billion
  • Q2 2024

A detailed history of Ameriprise Financial Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Ameriprise Financial Inc holds 147,717 shares of TEVA stock, worth $2.59 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
147,717
Previous 96,533 53.02%
Holding current value
$2.59 Million
Previous $1.36 Million 76.21%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$12.78 - $17.4 $654,131 - $890,601
51,184 Added 53.02%
147,717 $2.4 Million
Q1 2024

May 15, 2024
SELL
$10.67 - $14.43 $10,883 - $14,718
-1,020 Reduced 1.05%
96,533 $1.36 Million
Q4 2023

Feb 14, 2024
BUY
$8.12 - $10.63 $2,712 - $3,550
334 Added 0.34%
97,553 $1.02 Million
Q3 2023

Nov 14, 2023
BUY
$7.48 - $10.7 $38,484 - $55,051
5,145 Added 5.59%
97,219 $991,000
Q2 2023

Aug 14, 2023
SELL
$7.2 - $9.47 $184,903 - $243,199
-25,681 Reduced 21.81%
92,074 $693,000
Q1 2023

May 15, 2023
SELL
$8.36 - $11.37 $18,032 - $24,525
-2,157 Reduced 1.8%
117,755 $1.04 Million
Q4 2022

Feb 14, 2023
BUY
$7.95 - $9.48 $369,873 - $441,057
46,525 Added 63.4%
119,912 $1.09 Million
Q3 2022

Nov 14, 2022
SELL
$6.86 - $11.95 $438,367 - $763,628
-63,902 Reduced 46.55%
73,387 $592,000
Q2 2022

Aug 15, 2022
SELL
$7.38 - $10.4 $296,159 - $417,352
-40,130 Reduced 22.62%
137,289 $1.03 Million
Q1 2022

May 16, 2022
BUY
$7.33 - $9.39 $650,596 - $833,437
88,758 Added 100.11%
177,419 $1.66 Million
Q4 2021

Feb 14, 2022
SELL
$7.9 - $10.19 $56,287 - $72,603
-7,125 Reduced 7.44%
88,661 $700,000
Q3 2021

Nov 15, 2021
SELL
$8.38 - $10.18 $283,386 - $344,257
-33,817 Reduced 26.09%
95,786 $933,000
Q2 2021

Aug 16, 2021
SELL
$9.9 - $11.56 $1.01 Million - $1.17 Million
-101,621 Reduced 43.95%
129,603 $1.28 Million
Q1 2021

May 17, 2021
SELL
$10.34 - $12.81 $207,906 - $257,570
-20,107 Reduced 8.0%
231,224 $2.67 Million
Q4 2020

Feb 12, 2021
SELL
$8.61 - $11.04 $2.45 Million - $3.15 Million
-285,116 Reduced 53.15%
251,331 $2.42 Million
Q3 2020

Nov 16, 2020
BUY
$8.57 - $12.69 $1.7 Million - $2.52 Million
198,491 Added 58.73%
536,447 $4.83 Million
Q2 2020

Aug 14, 2020
SELL
$8.12 - $13.12 $2.07 Million - $3.34 Million
-254,557 Reduced 42.96%
337,956 $4.17 Million
Q1 2020

May 15, 2020
SELL
$6.69 - $13.45 $86,990 - $174,890
-13,003 Reduced 2.15%
592,513 $5.32 Million
Q4 2019

Feb 14, 2020
BUY
$6.53 - $10.72 $1.98 Million - $3.25 Million
302,970 Added 100.14%
605,516 $5.94 Million
Q3 2019

Nov 14, 2019
BUY
$6.16 - $9.6 $503,672 - $784,944
81,765 Added 37.03%
302,546 $2.08 Million
Q2 2019

Aug 14, 2019
BUY
$8.12 - $15.72 $499,696 - $967,393
61,539 Added 38.64%
220,781 $2.04 Million
Q1 2019

May 15, 2019
SELL
$15.58 - $20.01 $630,865 - $810,244
-40,492 Reduced 20.27%
159,242 $2.5 Million
Q4 2018

Feb 14, 2019
SELL
$14.59 - $23.84 $486,430 - $794,825
-33,340 Reduced 14.3%
199,734 $3.08 Million
Q3 2018

Nov 14, 2018
BUY
$21.06 - $25.65 $995,990 - $1.21 Million
47,293 Added 25.46%
233,074 $5.01 Million
Q2 2018

Aug 14, 2018
SELL
$16.77 - $24.71 $138,386 - $203,906
-8,252 Reduced 4.25%
185,781 $4.51 Million
Q1 2018

May 15, 2018
BUY
$16.68 - $22.07 $1.62 Million - $2.15 Million
97,322 Added 100.63%
194,033 $3.32 Million
Q4 2017

Feb 12, 2018
SELL
$11.23 - $19.1 $15.2 Million - $25.9 Million
-1,356,425 Reduced 93.34%
96,711 $1.86 Million
Q3 2017

Nov 07, 2017
BUY
$15.41 - $32.17 $22.4 Million - $46.7 Million
1,453,136
1,453,136 $25.6 Million

Others Institutions Holding TEVA

# of Institutions
617
Shares Held
563M
Call Options Held
25.2M
Put Options Held
5.08M
View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Quotes by TradingView
  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Ameriprise Financial Inc Portfolio

Follow Ameriprise Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email